Drawing for OLIGODISC

USPTO serial 79438362

OLIGODISC

Reviewed by CopyMark Law Group

Reg. 8374794Status 700Registered
Filing date
Status date
Registration date
Aug 4, 2026
Examiner
PEISECKI, MARK A
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with OLIGODISC?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Julie A. Greenberg

Julie A. Greenberg Reising Ethington P.C.755 W. Big Beaver Rd, Suite 1850Troy, MI 48084United States

Goods and services

ClassDescriptionStatusFirst use
042Research and development services in the field of pharmaceuticals and drug discovery; development of processes and methods for Pharmaceutical drug development for medical and veterinary purposes; development of medical and veterinary preparations; scientific research for medical purposes, namely, screening for the identification of drug candidates for scientific research purposes; development of precision RNA therapeutic pharmaceuticals; medical research in the nature of the development of tailored RNA-based corrective interventions to target the root causes of serious diseases; research and development of new medical products for others; medical research in the nature of the development and identification of novel druggable sites for pharmacological intervention using a bioinformatic discovery platform in a wet lab; Drug screening for scientific research purposes; Scientific research relating to bioinformatics services and modelling services to harness natural processes and modulate gene expression through platforms to generate optimized small molecules, antisense oligonucleotides (ASOs) and small interfering RNAs (siRNAs); Scientific research relating to designing and developing algorithms and thermodynamic models.ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 4, 2026NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Aug 4, 2026R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 16, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 16, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 10, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 20, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 11, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 11, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 11, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 5, 2026RFNTREFUSAL PROCESSED BY IB—
Feb 19, 2026RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Feb 19, 2026RFRRREFUSAL PROCESSED BY MPU—
Jan 24, 2026RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jan 23, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 13, 2026DOCKASSIGNED TO EXAMINER—
Dec 5, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Dec 5, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 4, 2025REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance